Search Result for "*:*"
Research & Publications

Aphase1a/ 1bfirst-in-human, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of oral TP-0903, a potent inhibitor of AXL kinase, administered daily for 21 days to patients with advanced solid tumors.

Research & Publications

The Role of Genetics in sporadic GEP-NETs: A Comprehensive Review of the Literature

Research & Publications

Aphase1a/ 1bfirst-in-human, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of oral TP-0903, a potent inhibitor of AXL kinase, administered daily for 21 days to patients with advanced solid tumors.

Research & Publications

Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine.

Research & Publications

The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration